F. Chédevergne

发表

Cytokine transcripts in pediatric tuberculosis: a study with bronchoalveolar cells.

B. Gicquel, J. de Blic, J. Colle, 2000, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Bioelectrical impedance in young patients with cystic fibrosis: Validation of a specific equation and clinical relevance.

J. Jais, I. Sermet-Gaudelus, G. Casimir, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Low bone mineral density in young children with cystic fibrosis.

J. Souberbielle, I. Sermet-Gaudelus, G. Lenoir, 2007, American journal of respiratory and critical care medicine.

Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization

J. Benichou, P. Reix, I. Pin, 2021, Pulmonary Therapy.

Predictive factors for lumacaftor/ivacaftor clinical response.

I. Sermet-Gaudelus, E. Girodon, A. Edelman, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?

I. Sermet-Gaudelus, A. Edelman, T. Flament, 2019, American journal of respiratory and critical care medicine.

"Il faut continuer à poser des questions" patient reported outcome measures in cystic fibrosis: An anthropological perspective.

P. Burgel, I. Sermet-Gaudelus, J. Bend, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The role of inflammation in childhood asthma

M. Le Bourgeois, J. de Blic, P. Scheinmann, 2000, Archives of disease in childhood.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

Profiling the response to lumacaftor‐ivacaftor in children with cystic between fibrosis and new insight from a French‐Italian real‐life cohort

P. Reix, V. Lucidi, C. Marguet, 2022, Pediatric pulmonology.

Proteomic profiling of sweat in patients with cystic fibrosis provides new insights into epidermal homoeostasis

I. Sermet-Gaudelus, T. Nguyen-Khoa, Vincent Jung, 2022, Skin health and disease.

Prevention of osteoporosis in cystic fibrosis.

I. Sermet-Gaudelus, F. Chédevergne, 2019, Current opinion in pulmonary medicine.

Persistent Bordetella bronchiseptica infection in a child with cystic fibrosis: Relationship to bacterial phenotype.

I. Sermet-Gaudelus, A. Ferroni, N. Guiso, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR.

I. Sermet-Gaudelus, E. Schneider-Futschik, Jérémy Dana, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis.

P. Böelle, P. Boelle, I. Sermet-Gaudelus, 2014, Vaccine.

Vaccine coverage in CF children: A French multicenter study.

I. Sermet-Gaudelus, O. Launay, H. Corvol, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[Inhaled treatments in cystic fibrosis: what's new in 2013?].

J. Dubus, F. Chédevergne, G. Reychler, 2014, Revue des maladies respiratoires.